Results for tag: "Natural Killer Cell"

The Natural Killer Cell market within the context of Oncology Drugs is a rapidly growing field of research and development. Natural Killer Cells (NK Cells) are a type of white blood cell that play an important role in the body's immune system. They are capable of recognizing and destroying cancer cells, as well as other abnormal cells. NK Cells have been used in the treatment of various types of cancer, including leukemia, lymphoma, and multiple myeloma. NK Cells have also been used in combination with other treatments, such as chemotherapy and radiation therapy, to improve the efficacy of these treatments. In recent years, the development of NK Cell-based therapies has been a major focus of research and development in the oncology drug market. Several companies have developed NK Cell-based therapies, including CAR-T therapies, which are designed to target and destroy cancer cells. These therapies have shown promising results in clinical trials and are being evaluated for their potential to treat a variety of cancers. Companies in the Natural Killer Cell market within the context of Oncology Drugs include Kite Pharma, Juno Therapeutics, Novartis, and Celgene. Show Less Read more